206 related articles for article (PubMed ID: 34510504)
1. Analysis of the growing public interest in selective androgen receptor modulators.
Efimenko IV; Chertman W; Masterson TA; Dubin JM; Ramasamy R
Andrologia; 2021 Dec; 53(11):e14238. PubMed ID: 34510504
[TBL] [Abstract][Full Text] [Related]
2. Adverse effects and potential benefits among selective androgen receptor modulators users: a cross-sectional survey.
Efimenko IV; Valancy D; Dubin JM; Ramasamy R
Int J Impot Res; 2022 Dec; 34(8):757-761. PubMed ID: 34471228
[TBL] [Abstract][Full Text] [Related]
3. Considerations, possible contraindications, and potential mechanisms for deleterious effect in recreational and athletic use of selective androgen receptor modulators (SARMs) in lieu of anabolic androgenic steroids: A narrative review.
Machek SB; Cardaci TD; Wilburn DT; Willoughby DS
Steroids; 2020 Dec; 164():108753. PubMed ID: 33148520
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of the SARMs: revisiting the androgen receptor for drug discovery.
Segal S; Narayanan R; Dalton JT
Expert Opin Investig Drugs; 2006 Apr; 15(4):377-87. PubMed ID: 16548787
[TBL] [Abstract][Full Text] [Related]
5. Androgens and Selective Androgen Receptor Modulators to Treat Functional Limitations Associated With Aging and Chronic Disease.
Bhasin S; Krishnan V; Storer TW; Steiner M; Dobs AS
J Gerontol A Biol Sci Med Sci; 2023 Jun; 78(Suppl 1):25-31. PubMed ID: 37325955
[TBL] [Abstract][Full Text] [Related]
6. Development of selective androgen receptor modulators (SARMs).
Narayanan R; Coss CC; Dalton JT
Mol Cell Endocrinol; 2018 Apr; 465():134-142. PubMed ID: 28624515
[TBL] [Abstract][Full Text] [Related]
7. Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer.
Dalton JT; Taylor RP; Mohler ML; Steiner MS
Curr Opin Support Palliat Care; 2013 Dec; 7(4):345-51. PubMed ID: 24189892
[TBL] [Abstract][Full Text] [Related]
8. Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications.
Solomon ZJ; Mirabal JR; Mazur DJ; Kohn TP; Lipshultz LI; Pastuszak AW
Sex Med Rev; 2019 Jan; 7(1):84-94. PubMed ID: 30503797
[TBL] [Abstract][Full Text] [Related]
9. Selective androgen receptor modulators (SARMs) as pharmacological treatment for muscle wasting in ongoing clinical trials.
Fonseca GWPD; Dworatzek E; Ebner N; Von Haehling S
Expert Opin Investig Drugs; 2020 Aug; 29(8):881-891. PubMed ID: 32476495
[TBL] [Abstract][Full Text] [Related]
10. Selective androgen receptor modulators as function promoting therapies.
Bhasin S; Jasuja R
Curr Opin Clin Nutr Metab Care; 2009 May; 12(3):232-40. PubMed ID: 19357508
[TBL] [Abstract][Full Text] [Related]
11. Comparative safety evaluation of selective androgen receptor modulators and anabolic androgenic steroids.
Choi SM; Lee BM
Expert Opin Drug Saf; 2015; 14(11):1773-85. PubMed ID: 26401842
[TBL] [Abstract][Full Text] [Related]
12. Overview of the development of selective androgen receptor modulators (SARMs) as pharmacological treatment for osteoporosis (1998-2021).
Xie Y; Tian Y; Zhang Y; Zhang Z; Chen R; Li M; Tang J; Bian J; Li Z; Xu X
Eur J Med Chem; 2022 Feb; 230():114119. PubMed ID: 35063736
[TBL] [Abstract][Full Text] [Related]
13. Selective androgen receptor modulators: in pursuit of tissue-selective androgens.
Omwancha J; Brown TR
Curr Opin Investig Drugs; 2006 Oct; 7(10):873-81. PubMed ID: 17086931
[TBL] [Abstract][Full Text] [Related]
14. Selective androgen receptor modulators: the future of androgen therapy?
Christiansen AR; Lipshultz LI; Hotaling JM; Pastuszak AW
Transl Androl Urol; 2020 Mar; 9(Suppl 2):S135-S148. PubMed ID: 32257854
[TBL] [Abstract][Full Text] [Related]
15. Identification and Synthesis of Selected In Vitro Generated Metabolites of the Novel Selective Androgen Receptor Modulator (SARM) 2f.
Möller T; Wen HC; Naumann N; Krug O; Thevis M
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513414
[TBL] [Abstract][Full Text] [Related]
16. Characterization of equine urinary metabolites of selective androgen receptor modulators (SARMs) S1, S4 and S22 for doping control purposes.
Hansson A; Knych H; Stanley S; Thevis M; Bondesson U; Hedeland M
Drug Test Anal; 2015 Aug; 7(8):673-83. PubMed ID: 25560998
[TBL] [Abstract][Full Text] [Related]
17. Novel, non-steroidal, selective androgen receptor modulators (SARMs) with anabolic activity in bone and muscle and improved safety profile.
Rosen J; Negro-Vilar A
J Musculoskelet Neuronal Interact; 2002 Mar; 2(3):222-4. PubMed ID: 15758439
[TBL] [Abstract][Full Text] [Related]
18. A screening method for the quantitative determination of selective androgen receptor modulators (SARMs) in capsules by high resolution
Maccelli A; Borioni A; Aureli F; Gaudiano MC; Manna L; Raimondo M
Anal Methods; 2024 Apr; 16(14):2135-2146. PubMed ID: 38517236
[TBL] [Abstract][Full Text] [Related]
19. Understanding and managing the suppression of spermatogenesis caused by testosterone replacement therapy (TRT) and anabolic-androgenic steroids (AAS).
Desai A; Yassin M; Cayetano A; Tharakan T; Jayasena CN; Minhas S
Ther Adv Urol; 2022; 14():17562872221105017. PubMed ID: 35783920
[TBL] [Abstract][Full Text] [Related]
20. Nonsteroidal selective androgen receptor modulators enhance female sexual motivation.
Jones A; Hwang DJ; Duke CB; He Y; Siddam A; Miller DD; Dalton JT
J Pharmacol Exp Ther; 2010 Aug; 334(2):439-48. PubMed ID: 20444881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
